Nice Brand Lab aims to double revenue of ellesse footwear in 2026
Nice Brand Lab, a division of Italian producer Nice Footwear, set up in July 2024 to manufacture and distribute sneakers and leisure footwear for proprietary and licensed brands, has ambitious plans for ellesse, a long-standing Italian sportswear brand owned by British company Pentland.
Nice Brand Lab (NBL) already held the license to develop, manufacture, and distribute ellesse shoes in Italy and France, and has recently inked a global partnership deal with Pentland for the brand's footwear. In February, NBL appointed Nick Carlisle as strategic business developer for ellesse.
'We have comprehensively overhauled the European sales organisation. In Italy, we have switched from 13 agents to 6 macro areas, for better coverage on the ground. Our next targets are the USA, where we plan to enter with Spring/Summer 2026 via a premium e-tailer, to then open our first monobrand stores with Fall/Winter 2026-27; and the APAC region, especially Japan, Korea, China, and Indonesia,' said Carlisle, speaking to FashionNetwork.com. 'In addition, we're focusing on women's shoes, which currently account for 40% of sales, a share we're keen to grow to 60% by winter 2026-27. We'll then turn to the children's range, so far quite limited, which we'll start to extend from the Spring/Summer 2027.'
A well-defined roadmap, through which NBL is aiming to double the revenue of ellesse's footwear division, making the brand once again a member of sportswear's elite circle: 'We want to take ellesse back on court, we're negotiating with women tennis professionals and we'll work on developing performance footwear. By 2030, we want to become Italy's top sportswear brand, and rank among the world's top 10,' added Carlisle.
NBL is keen to revitalise ellesse's long-standing connection with tennis, as demonstrated by the vast ellesse stand at the Pitti Uomo show, a giant replica of a tennis court including oversize rackets and balls. 'For Spring/Summer 2026 we've presented an entirely revamped collection based on a 'less is more' concept, reducing SKUs to focus on our heritage,' said Carlisle.
ellesse was spawned by the pioneering vision of Leonardo Servadio, who in 1959 boldly decided to mix sportswear with Italian tailoring elegance. A heritage ellesse is celebrating with next summer's collection, designed as 'a tribute to Italian style and effortless charm, on and off the court.' The Spring/Summer 2026 footwear line created by NBL features several new models characterised by a strong identity and unique design, marking a new creative direction for ellesse. The line is innovative both in terms of style, more deliberately sophisticated, and product construction, and is designed to express a more mature, distinctive vision of a sporting lifestyle.
One of the new collection's stand-out items is the LS914, a signature off-court sneakers model named after the height of tennis court nets (91.4 cm): 'With its bold lines, decisive volume and strong visual identity, the LS914 is a tribute to contemporary design, perfectly balanced between sport and lifestyle,' said ellesse.
In addition to focusing on ellesse, NBL is tapping Carlisle's expertise to develop a new business line: 'We're putting our know-how at the disposal of brands interested in launching footwear or strengthening their position in the segment. We can offer them a comprehensive suite of services and advice, from style to production, distribution, marketing and communication,' concluded Carlisle, adding that 'for the Spring/Summer 2026, we are negotiating with various interested parties, chiefly apparel brands that want to expand into footwear.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Fashion Network
2 hours ago
- Fashion Network
Orlebar Brown and VEA Newport Beach collaborate poolside
It's a collaboration tailor-made for a poolside summer: British men's beachwear specialist Orlebar Brown and luxury Southern California resort VEA Newport Beach (billed as 'Newport's social sanctuary'). The timely coming together coincides with Chanel -owned Orlebar Brown opening a store on Fashion Island in Orange County California, and the pair have hosted a pop-up store within VEA's poolside cabana that also offered 'a fleet of on-site amenities' including an in-room shopping concierge, a signature cocktail, and certificates to shop at the brand-new flagship across the street from the resort'. Every Saturday in June, Orlebar Brown has been activating the cabana at VEA's pool with custom upholsteries, branded pool accessories, and a sampling of the brand's latest collection. In every VEA room, guests can find hanger tags that activate a personal shopping concierge able to deliver product from the Fashion Island store, located steps away from the resort while guests staying in VEA suites throughout the month will receive a $250 Orlebar Brown gift certificate. 'VEA provides the perfect backdrop for a luxury fashion experience,' said Debbie Snavely, GM of VEA Newport Beach Marriott. 'Orlebar Brown embodies the essence of our guests — elegant yet approachable, relaxed yet polished.' It's the latest opening for Orlebar Brown which operates 50 direct stores including London, Paris, New York, Miami, Los Angeles, Sydney, Dubai, St Tropez, Marbella, Ibiza, Mykonos, Athens, Montecito, St Barths and East Hampton.
Fashion Network
4 hours ago
- Fashion Network
Nice Brand Lab aims to double revenue of ellesse footwear in 2026
Nice Brand Lab, a division of Italian producer Nice Footwear, set up in July 2024 to manufacture and distribute sneakers and leisure footwear for proprietary and licensed brands, has ambitious plans for ellesse, a long-standing Italian sportswear brand owned by British company Pentland. Nice Brand Lab (NBL) already held the license to develop, manufacture, and distribute ellesse shoes in Italy and France, and has recently inked a global partnership deal with Pentland for the brand's footwear. In February, NBL appointed Nick Carlisle as strategic business developer for ellesse. 'We have comprehensively overhauled the European sales organisation. In Italy, we have switched from 13 agents to 6 macro areas, for better coverage on the ground. Our next targets are the USA, where we plan to enter with Spring/Summer 2026 via a premium e-tailer, to then open our first monobrand stores with Fall/Winter 2026-27; and the APAC region, especially Japan, Korea, China, and Indonesia,' said Carlisle, speaking to 'In addition, we're focusing on women's shoes, which currently account for 40% of sales, a share we're keen to grow to 60% by winter 2026-27. We'll then turn to the children's range, so far quite limited, which we'll start to extend from the Spring/Summer 2027.' A well-defined roadmap, through which NBL is aiming to double the revenue of ellesse's footwear division, making the brand once again a member of sportswear's elite circle: 'We want to take ellesse back on court, we're negotiating with women tennis professionals and we'll work on developing performance footwear. By 2030, we want to become Italy's top sportswear brand, and rank among the world's top 10,' added Carlisle. NBL is keen to revitalise ellesse's long-standing connection with tennis, as demonstrated by the vast ellesse stand at the Pitti Uomo show, a giant replica of a tennis court including oversize rackets and balls. 'For Spring/Summer 2026 we've presented an entirely revamped collection based on a 'less is more' concept, reducing SKUs to focus on our heritage,' said Carlisle. ellesse was spawned by the pioneering vision of Leonardo Servadio, who in 1959 boldly decided to mix sportswear with Italian tailoring elegance. A heritage ellesse is celebrating with next summer's collection, designed as 'a tribute to Italian style and effortless charm, on and off the court.' The Spring/Summer 2026 footwear line created by NBL features several new models characterised by a strong identity and unique design, marking a new creative direction for ellesse. The line is innovative both in terms of style, more deliberately sophisticated, and product construction, and is designed to express a more mature, distinctive vision of a sporting lifestyle. One of the new collection's stand-out items is the LS914, a signature off-court sneakers model named after the height of tennis court nets (91.4 cm): 'With its bold lines, decisive volume and strong visual identity, the LS914 is a tribute to contemporary design, perfectly balanced between sport and lifestyle,' said ellesse. In addition to focusing on ellesse, NBL is tapping Carlisle's expertise to develop a new business line: 'We're putting our know-how at the disposal of brands interested in launching footwear or strengthening their position in the segment. We can offer them a comprehensive suite of services and advice, from style to production, distribution, marketing and communication,' concluded Carlisle, adding that 'for the Spring/Summer 2026, we are negotiating with various interested parties, chiefly apparel brands that want to expand into footwear.'
Euronews
4 hours ago
- Euronews
Could Europe bring in top research talent from the US?
US government spending on health research has reached a 10-year low, forcing universities to draw from their savings and hurting companies that sell lab supplies. Researchers who pursued global health, race, gender identity, climate change and topics related to diversity, equity and inclusion also saw their grants terminated. This has led to three-quarters of US-based respondents in a Nature poll considering leaving the country, creating an opportunity for the EU to attract researchers from the US. "We believe that diversity is an asset of humanity and the lifeblood of science. It is one of the most valuable global goods, and it must be protected," European Commission President Ursula von der Leyen said in May in a speech delivered at La Sorbonne University in Paris. In 2024, the US accounted for 36% of all highly cited researchers, compared to 21% in China and 19% in the EU (including Switzerland and Norway), according to a Bruegel analysis. While the EU retains a significant portion of its own talent, it also contributes substantially to the global pool of mobile top researchers, particularly to the US. Among US-based highly cited researchers at Harvard, Princeton, the University of Pennsylvania and Columbia, 7.7% earned their PhD in the EU. A large portion of the US-based top research workforce also has an international education, with 24% of US-based highly cited researchers being entirely educated abroad. Family ties, personal life plans and career prospects are among the factors that can persuade researchers to move countries. However, there is still a large salary gap between US and EU academics. A top researcher at the University of California can earn between $500,000 (€432,300) and over $1 million (€865,240) annually. In contrast, even the highest-paid professors at top European institutions such as Spain's Complutense University of Madrid typically earn no more than €77,122. Initiatives such as Choose Europe, which includes a €500 million package aimed at attracting researchers to Europe, alongside efforts to reduce barriers for international students and researchers, could lead to essential changes in the long run. For instance, Provence-Aix Marseille University reported being "inundated" with applications from US-based researchers after announcing the launch of the three-year Safe Place For Science program, where they expect to raise €15 million and host around 15 researchers. Yet, between 2022 and 2024, the most attractive destinations among US graduates who wanted to move abroad were the United Kingdom and Canada. "Life-changing plans take time, and it is too early to expect a massive outflow from the US," the Bruegel analysis stated. But 30 years of exposure to glyphosate has shattered his dreams and his existence. He was diagnosed five years ago with an intravascular B-cell lymphoma, a rare form of cancer. It has been recognised as an occupational disease. Glyphosate is the most widely used herbicide in the world and also the most controversial. It has been classified as 'probably carcinogenic' by the International Agency for Research on Cancer (IARC) since 2015. More recent studies from research institutes such as the French National Institute of Health and Medical Research (INSERM) have established a likely link between exposure to the chemical and certain forms of cancer. Yet, the European Union has extended its authorisation until 2033, relying on studies by EFSA and ECHA, the European authorities for food and chemical safety. Several environmental and consumer rights organisations challenged the decision before the European Court of Justice last April. The gap between assessments results from the methodologies used by research institutes and European regulatory agencies, according to Xavier Coumoul, a toxicologist and researcher at Inserm in France. 'When a pesticide manufacturer wants to market a product, the regulatory agencies require the manufacturer to conduct its own tests to prove the product is safe,' he explains. This process raises many questions surrounding the independence of these surveys. 'EFSA gives little consideration to epidemiological studies and relies considerably on what the industry provides, whereas Inserm or IARC rely much more on the academic literature and monitoring real-life product use.' Ludovic Maugé, whose life now hangs by a thread, is among those for whom the product's toxicity is undeniable. After undergoing more chemotherapy than is usually permitted, his last hope, he says, is a transplant using his own modified stem cells. It's a vanishingly small chance. 'As my oncologist told me, we can no longer speak of a cure,' he confides. Since his cancer was recognised as an occupational disease, Ludovic receives a modest social allowance, along with monthly compensation of 180 euros from Bayer-Monsanto — which manufactured the product that poisoned him. 'It's a pittance, but I don't care. What mattered most to me was to see my illness recognised as work-related.' Despite his daily ordeal, Ludovic, who can no longer work, wants to take his fight further. 'What I want is to spread the message to everyone. Glyphosate destroyed my life — it poisoned me. These products destroy people and destroy nature,' he insists. He is outraged by the EU's decision to renew glyphosate's authorisation. 'When I see politicians reauthorising these products, it makes me furious. It's the pesticide lobby. Unfortunately, we can't do anything against these politicians and Bayer-Monsanto. If I had one thing to say to the European Union, it's this: just ban these products. That's it.'
